G D Batty1, M J Shipley, M Marmot, G Davey Smith. 1. Epidemiology Unit, London School of Hygiene and Tropical Medicine and Department of Epidemiology and Public Health, University College London, UK. david.batty@lshtm.ac.uk
Abstract
AIMS: Given that studies of individuals with Type 2 diabetes or impaired glucose tolerance indicate that physical activity has a normalizing effect on several indices of coronary heart disease (CHD) risk-including body weight, blood pressure, blood lipids, and cardiorespiratory fitness-it is plausible that activity may reduce CHD incidence in this group in the long term. The aim of the present analysis was to explore this hypothesis using data from a prospective observational study. METHODS: We examined the relation of two indices of physical activity-walking pace and leisure activity-to total mortality, CHD, and other cardiovascular diseases in a 25-year follow-up of 6408 male British Civil Servants who underwent an oral glucose tolerance test at study entry. RESULTS: In 352 men who were identified as having Type 2 diabetes or impaired glucose tolerance (diabetes/IGT) at baseline, 215 had died at follow-up and, in 6056 normoglycaemics, 2550 deaths had occurred. The two indices of physical activity were inversely related to all-cause, CHD, and other cardiovascular disease mortality in both normoglycaemics and in men with diabetes/IGT. Although these associations were attenuated somewhat after statistical adjustment for a range of covariates, the majority held, suggesting an independent effect for physical activity. The gradient of the activity-mortality association was steeper in individuals with diabetes/IGT in comparison with the normoglycaemics, with the linear trend across activity levels for CHD risk differing markedly in the analyses of both walking pace (P-value for interaction test = 0.05) and leisure activity (P-value = 0.02). CONCLUSIONS: The findings of the present analysis of men with Type 2 diabetes/IGT provide support for those from a small number of other studies of persons with Type 2 diabetes suggesting that this group may benefit from physical activity in terms of CHD risk reduction.
AIMS: Given that studies of individuals with Type 2 diabetes or impaired glucose tolerance indicate that physical activity has a normalizing effect on several indices of coronary heart disease (CHD) risk-including body weight, blood pressure, blood lipids, and cardiorespiratory fitness-it is plausible that activity may reduce CHD incidence in this group in the long term. The aim of the present analysis was to explore this hypothesis using data from a prospective observational study. METHODS: We examined the relation of two indices of physical activity-walking pace and leisure activity-to total mortality, CHD, and other cardiovascular diseases in a 25-year follow-up of 6408 male British Civil Servants who underwent an oral glucose tolerance test at study entry. RESULTS: In 352 men who were identified as having Type 2 diabetes or impaired glucose tolerance (diabetes/IGT) at baseline, 215 had died at follow-up and, in 6056 normoglycaemics, 2550 deaths had occurred. The two indices of physical activity were inversely related to all-cause, CHD, and other cardiovascular disease mortality in both normoglycaemics and in men with diabetes/IGT. Although these associations were attenuated somewhat after statistical adjustment for a range of covariates, the majority held, suggesting an independent effect for physical activity. The gradient of the activity-mortality association was steeper in individuals with diabetes/IGT in comparison with the normoglycaemics, with the linear trend across activity levels for CHD risk differing markedly in the analyses of both walking pace (P-value for interaction test = 0.05) and leisure activity (P-value = 0.02). CONCLUSIONS: The findings of the present analysis of men with Type 2 diabetes/IGT provide support for those from a small number of other studies of persons with Type 2 diabetes suggesting that this group may benefit from physical activity in terms of CHD risk reduction.
Authors: Jacob Sattelmair; Jeremy Pertman; Eric L Ding; Harold W Kohl; William Haskell; I-Min Lee Journal: Circulation Date: 2011-08-01 Impact factor: 29.690
Authors: George B Ploubidis; Wanjiku Mathenge; Bianca De Stavola; Emily Grundy; Allen Foster; Hannah Kuper Journal: Int J Public Health Date: 2012-07-20 Impact factor: 3.380
Authors: Monideepa B Becerra; Monideepa Bhattacharya Becerra; Patti Herring; Helen Hopp Marshak; Jim E Banta Journal: J Immigr Minor Health Date: 2015-08
Authors: William M Schultz; Elliot N Mahlof; Devinder S Dhindsa; Tina Varghese; Robert E Heinl; Hannah C Cai; Pratik B Sandesara; Danny J Eapen; Laurence S Sperling Journal: Cardiovasc Endocrinol Date: 2017-11-15
Authors: O Kenrik Duru; Robert B Gerzoff; Arleen F Brown; Andrew J Karter; Catherine Kim; David Kountz; K M Venkat Narayan; Stephen H Schneider; Chien-Wen Tseng; Beth Waitzfelder; Carol M Mangione Journal: J Gen Intern Med Date: 2008-05-02 Impact factor: 5.128
Authors: H Sone; S Tanaka; S Tanaka; S Suzuki; H Seino; O Hanyu; A Sato; T Toyonaga; K Okita; S Ishibashi; S Kodama; Y Akanuma; N Yamada Journal: Diabetologia Date: 2013-02-27 Impact factor: 10.122